Serum levels of IL-17A in patients with relapsing–remitting multiple sclerosis treated with interferon-β
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum levels of IL-17A in patients with relapsing–remitting multiple sclerosis treated with interferon-β
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 19, Issue 7, Pages 885-890
Publisher
SAGE Publications
Online
2012-12-04
DOI
10.1177/1352458512468497
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum IL-17F does not predict poor response to IM IFN -1a in relapsing-remitting MS
- (2012) S. E. Bushnell et al. NEUROLOGY
- Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial
- (2011) Douglas S Goodin et al. Multiple Sclerosis Journal
- Th17 Cell, the New Player of Neuroinflammatory Process in Multiple Sclerosis
- (2011) F. Jadidi-Niaragh et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Interferon-β exacerbates Th17-mediated inflammatory disease
- (2011) Robert C. Axtell et al. TRENDS IN IMMUNOLOGY
- T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis
- (2010) Robert C Axtell et al. NATURE MEDICINE
- Breakthrough disease during interferon- therapy in MS: No signs of impaired biologic response
- (2010) D. Hesse et al. NEUROLOGY
- T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-β
- (2009) Luca Durelli et al. ANNALS OF NEUROLOGY
- A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis
- (2009) M. Comabella et al. BRAIN
- Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis
- (2009) Verena Brucklacher-Waldert et al. BRAIN
- IFN- Inhibits Human Th17 Cell Differentiation
- (2009) V. S. Ramgolam et al. JOURNAL OF IMMUNOLOGY
- Current approaches to the identification and management of breakthrough disease in patients with multiple sclerosis
- (2009) Richard A Rudick et al. LANCET NEUROLOGY
- Multiple sclerosis pharmacogenomics: Maximizing efficacy of therapy
- (2009) D. J. Pappas et al. NEUROLOGY
- IL17 and IFNγ production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis
- (2008) Giovanni Frisullo et al. CYTOKINE
- T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis
- (2008) Chris J. Hedegaard et al. IMMUNOLOGY
- A rush to judgment on Th17: Figure 1.
- (2008) Lawrence Steinman JOURNAL OF EXPERIMENTAL MEDICINE
- Interleukin-17 in transverse myelitis and multiple sclerosis
- (2008) J GRABER et al. JOURNAL OF NEUROIMMUNOLOGY
- Clinical markers of therapeutic response to disease modifying drugs
- (2008) Carlo Pozzilli et al. NEUROLOGICAL SCIENCES
- Interferon-beta responders and non-responders. A biological approach
- (2008) Antonio Bertolotto et al. NEUROLOGICAL SCIENCES
- Interleukin-17—Extended Features of a Key Player in Multiple Sclerosis
- (2007) Ralf Gold et al. AMERICAN JOURNAL OF PATHOLOGY
- Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis
- (2007) John S. Tzartos et al. AMERICAN JOURNAL OF PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started